netFormulary Oxfordshire Clinical Commissioning Group NHS
Formulary  
 Search
 Formulary Chapter 5: Infections - Full Chapter
Chapter Links...
 Details...
05.03.01  Expand sub section  HIV infection
05.03.01  Expand sub section  Nucleoside reverse transcriptase inhibitors
05.03.01  Expand sub section  Protease inhibitors
05.03.01  Expand sub section  Non-nucleoside reverse transcriptase inhibitors
05.03.01  Expand sub section  Other antiretrovirals to top
Dolutegravir (Tivicay®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

For use by Infectious Diseases and Genito-urinary Medicine only.

Funded by specialised commissioning.

 
   
Dolutegravir, abacavir & lamivudine (Triumeq®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

For use by Infectious Diseases and Genito-urinary Medicine only.

Funded by specialised commissioning.

 
   
Enfuvirtide (Fuzeon®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

For use by Infectious Diseases and Genito-urinary Medicine only.

Funded by specialised commissioning.

APCO September 2005.

 
   
Maraviroc (Celsentri®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

For use by Infectious Diseases and Genito-urinary Medicine only.

Funded by specialised commissioning.

APCO January 2011.

 
   
Raltegravir (Isentress®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
  • For use by Infectious Diseases and Genito-urinary Medicine only (APCO January 2011).
  • For use as first-line for Post-Exposure Prophylaxis (PEP) or HIV for paediatrics (APCO November 2017).

Funded by specialised commissioning.

 
   
05.03.01  Expand sub section  Pharmacokinetic enhancers of anti-retrovirals
05.03.01  Expand sub section  Combination Products
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Red: Medicines which should only be prescribed in secondary care by a specialist.  

Amber Continuation

Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred.   

Amber Shared Care Protocol

Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO).   

Green

Green: Medicines which are suitable for initiation and ongoing prescribing within primary care.   

Brown

Brown: Medicines which should only be prescribed in restricted circumstances.  

Black

Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety.  

OCCG Green

not used  

netFormulary